Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials

Autor: Mohamed Sayed Zaazouee, Rokaya Y. Ebrahim, Ghaida’a Al-araj, Ibram Zaki, Ahmed Saad, Abdullah Mohamed Farhat, Mustafa Hussein Ali, Mohamed Elshennawy, Omar Khaled Fahmy Fawy, Hadi F. Ahmed, Ziad Alahmad, Eman Ayman Nada, Reem I. Abo-Hamra, Ahmed Bostamy Elsnhory, Mohammed Eleyan, Hazem AbuEl-Enien, Rasha Abdo Elromely, Yossef Hassan AbdelQadir, Jaffer Shah, Alaa Ahmed Elshanbary

Publikováno v: The Egyptian Journal of Neurology, Psychiatry and Neurosurgery, Vol 60, Iss 1, Pp 1-15 (2024)

Abstract Background The humanized monoclonal antibody galcanezumab is an anti-calcitonin-gene-related-peptide (CGRP) and frequently used for migraine prevention. However, the literature revealed limited data with conflicting results. This study aims

Externí odkaz: https://doaj.org/article/6bfd72377cf642e7a03b4d230493d28f

Safety and efficacy of galcanezumab in chronic and episodic migraine patients: a systematic review and meta-analysis of randomized controlled trials.

Autor: Zaazouee, Mohamed Sayed¹ (AUTHOR) MohamedZaazouee.stu.6.44@azhar.edu.eg, Ebrahim, Rokaya Y.² (AUTHOR), Al-araj, Ghaida'a³ (AUTHOR), Zaki, Ibram⁴ (AUTHOR), Saad, Ahmed⁵ (AUTHOR), Farhat, Abdullah Mohamed⁶ (AUTHOR), Ali, Mustafa Hussein⁷ (AUTHOR), Elshennawy, Mohamed¹ (AUTHOR), Fawy, Omar Khaled Fahmy⁸ (AUTHOR), Ahmed, Hadi F.⁹ (AUTHOR), Alahmad, Ziad¹⁰ (AUTHOR), Nada, Eman Ayman¹¹ (AUTHOR), Abo-Hamra, Reem I.¹² (AUTHOR), Elsnhory, Ahmed Bostamy¹³ (AUTHOR), Eleyan, Mohammed¹⁴ (AUTHOR), AbuEl-Enien, Hazem¹⁵ (AUTHOR), Elromely, Rasha Abdo¹⁶ (AUTHOR), AbdelQadir, Yossef Hassan¹⁶ (AUTHOR), Shah, Jaffer¹⁷ (AUTHOR), Elshanbary, Alaa Ahmed¹⁶ (AUTHOR)

Publikováno v: Egyptian Journal of Neurology, Psychiatry & Neurosurgery. 5/13/2024, Vol. 60 Issue 1, p1-15. 15p.